AAAAAA
Results:
1-7
|
Results: 7
Authors:
Khaliq, Y
Gallicano, K
Tisdale, C
Carignan, G
Cooper, C
McCarthy, A
Citation: Y. Khaliq et al., Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers, BR J CL PH, 51(6), 2001, pp. 591-600
Authors:
Angel, JB
Khaliq, Y
Monpetit, ML
Cameron, DW
Gallicano, K
Citation: Jb. Angel et al., An argument for routine therapeutic drug monitoring of HIV-1 protease inhibitors during pregnancy, AIDS, 15(3), 2001, pp. 417-419
Authors:
Gallicano, K
Khaliq, Y
Carignan, G
Tseng, A
Walmsley, S
Cameron, DW
Citation: K. Gallicano et al., A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus, CLIN PHARM, 70(2), 2001, pp. 149-158
Authors:
Khaliq, Y
Gallicano, K
Seguin, I
Fyke, K
Carignan, G
Bulman, D
Badley, A
Cameron, DW
Citation: Y. Khaliq et al., Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease, BR J CL PH, 50(2), 2000, pp. 108-115
Authors:
Khaliq, Y
Gallicano, K
Leger, R
Foster, B
Badley, A
Citation: Y. Khaliq et al., A drug interaction between fusidic acid and a combination of ritonavir andsaquinavir, BR J CL PH, 50(1), 2000, pp. 82-83
Authors:
Khaliq, Y
Gallicano, K
Venance, S
Kravcik, S
Cameron, DW
Citation: Y. Khaliq et al., Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus, CLIN PHARM, 68(6), 2000, pp. 637-646
Authors:
Khaliq, Y
Gallicano, K
Sahai, J
Citation: Y. Khaliq et al., Introduction to drug interactions, INFEC DIS S, 2000, pp. 1-11
Risultati:
1-7
|